Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
143,581,013
-
Shares change
-
+9,945,793
-
Total reported value, excl. options
-
$1,730,907,955
-
Value change
-
+$111,334,758
-
Put/Call ratio
-
46.38%
-
Number of buys
-
75
-
Number of sells
-
-61
-
Price
-
$12.06
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2015
170 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q2 2015.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 143,581,013 shares
of 161,976,581 outstanding shares and own 88.64% of the company stock.
Largest 10 shareholders include FMR LLC (19,742,935 shares), WELLINGTON MANAGEMENT GROUP LLP (17,627,533 shares), JANUS CAPITAL MANAGEMENT LLC (15,579,815 shares), ORBIMED ADVISORS LLC (12,402,500 shares), VANGUARD GROUP INC (8,314,442 shares), DEUTSCHE BANK AG\ (7,565,022 shares), MORGAN STANLEY (6,313,653 shares), BlackRock Fund Advisors (5,886,692 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,189,700 shares), and STATE OF WISCONSIN INVESTMENT BOARD (4,957,980 shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.